Cargando…
Advances and Challenges in Biomarkers Use for Coronary Microvascular Dysfunction: From Bench to Clinical Practice
Coronary microvascular dysfunction (CMD) is related to a broad variety of clinical scenarios in which cardiac microvasculature is morphologically and functionally affected, and it is associated with impaired responses to vasoactive stimuli. Although the prevalence of CMD involves about half of all p...
Autores principales: | Rocco, Erica, Grimaldi, Maria Chiara, Maino, Alessandro, Cappannoli, Luigi, Pedicino, Daniela, Liuzzo, Giovanna, Biasucci, Luigi Marzio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999821/ https://www.ncbi.nlm.nih.gov/pubmed/35407662 http://dx.doi.org/10.3390/jcm11072055 |
Ejemplares similares
-
Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective
por: Biasucci, Luigi Marzio, et al.
Publicado: (2021) -
PREVALENCE AND CHARACTERISTICS OF MYOCARDIAL INJURY DURING COVID-19 PANDEMIC
por: Maino, Alessandro, et al.
Publicado: (2021) -
Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin
por: Maino, Alessandro, et al.
Publicado: (2021) -
Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional pro of CD4(+)T-lymphocytes in acute coronary syndromes
por: Severino, Anna, et al.
Publicado: (2017) -
Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome
por: Zara, Chiara, et al.
Publicado: (2017)